Dispelling Stasis and Detoxification Method based on COX-2/PGE2 Pathway
DOI:
https://doi.org/10.53469/jcmp.2024.06(09).10Keywords:
Inflammation, Inflammatory cancer transformation, PLGC, COX-2/PGE2Abstract
Gastric cancer is a disease with high mortality rate among global cancers, and its survival rate is extremely low and treatment prognosis is extremely poor, which seriously impedes the development of the world economy. Pre-cancerous gastric lesion (PLGC) is the early stage of gastric cancer, so far modern medicine has no effective measures to prevent and reverse the development of PLGC to gastric cancer, the pathogenesis of PLGC is not yet clear, but the theory of inflammatory cancer transformation is now more popular. Therefore, the COX-2/PGE2 pathway can generate an inflammatory environment, promote cell proliferation, inhibit apoptosis, promote angiogenesis and other processes, so that PLGC gradually develops into gastric cancer. According to Chinese medicine, gastric cancer is mostly caused by stagnation of qi and blood stasis, and the internalisation of fire and toxicity, so the elimination of blood stasis and detoxification fits the pathogenesis of the disease, and Chinese medicine can play an anti-inflammatory role in the COX-2/PGE2 pathway by inhibiting cell proliferation, promoting apoptosis, and inhibiting the formation of capillaries, which can prevent PLGCs from progressing to gastric cancer, and thus preventing the development of gastric cancer. This article reviews the pathogenesis of PLGC by COX-2/PGE2 signalling pathway, and the progress of TCM drugs targeting PLGC based on COX-2/PGE2 pathway by dispelling stasis and detoxification, with the aim of providing more theoretical basis and prescription research for clinical practice.
References
HE Jie, CHEN Wanqing, LI Zhaoshen, et al. Guidelines for screening and early diagnosis and treatment of gastric cancer in China (Beijing, 2022) [J]. Chinese Journal of Oncology, 2022, 44 (7): 634-666.
ZHANG Yanmei, WEI Jingjing, ZHU Zhongbo, LIU Senyu, YANG Fan, LIU Xiping, LI Peiqing. Progress of research on the mechanism of action of Semixia diarrhoea heart soup against gastric cancer[J/OL]. Chinese Journal of Experimental Formulas: 1-10 [2023-02-26].
Sahu A, Raza K, Pradhan D, Jain AK, Verma S. Cyclooxygenase-2 as a therapeutic target against human breast cancer: a comprehensive review. WIREs Mech Dis. 2023 Mar 28:e1596.
WANG Shiqi, WANG Mengqin, HAN Xuanmao, LIN Xuefeng, ZHANG Zhu. Research progress of acetylheparinase and cyclooxygenase-2 in atherosclerosis-related diseases[J]. Journal of Baotou Medical College, 2022, 38(10):91-96.
TAN Yeru. Relationship and mechanism of COX3 expression and promoter methylation of gastric cancer-related genes with pathological and clinical aspects of gastric cancer[D]. Nanhua University,2011.
Leslie, C. C. (2004). Regulation of arachidonic acid availability for eicosanoid production. Biochemistry and Cell Biology, 82(1), 1-17.
Regulski, M., Regulska, K., et, at al. (2016). COX-2 inhibitors: a novel strategy in the manage- ment of breast cancer. Drug Discovery Today, 21(4), 598-615. https://doi.org/10.1016/j.drudis.2015.12.003.
Botting, R. M. (2006). Inhibitors of cyclooxygenases: Mechanisms, selectivity and uses. Journal of Physiology and Pharmacology: An Official Journal of the Polish Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society, 57(Suppl 5), 113- 124.
Claar, D., Hartert, T. V., & Peebles, R. S. (2015). The role of prostaglandins in allergic lung inflammation and asthma. Expert Review of Respi- ratory Medicine, 9(1), 55-72. https://doi.org/10.1586/17476348.2015.992783
Singh-Ranger, G., Salhab, M., & Mokbel, K. (2008). The role of cyclooxygenase-2 in breast cancer: review. Breast Cancer Research and Treat-ment, 109(2), 189-198. Breast Cancer Research and Treat-ment, 109(2),189-198. https://doi.org/10.1007/s10549- 007- 9641-5
Smith, W. L., & Song, I. (2002). The enzymology of prostaglandin endoperoxide H synthases-1 and -2. Prostaglandins & Other Lipid Media-tors,68-69, 115 Prostaglandins & Other Lipid Media-tors,68-69, 115 -128. https://doi.org/10.1016/s0090-6980(02)00025-4
Rouzer, C. A., & Marnett, L. J. (2009). Cyclooxygenases: structural and functional insights. Journal of Lipid Research, 50(Suppl), S29-S34. https://doi.org/10.1194 /jlr.R800042-JLR200
Simmons, D. L., Botting, R. M., & Hla, T. (2004). Cyclooxygenase isozymes: The biology of prostaglandin synthesis and inhibition. Pharmaco- logical Reviews, 56(3), 387-437.
Desai, S. J., Prickril, B., & Rasooly, A. (2018). Mechanisms of phytonutrient modulation of cyclooxygenase-2 (COX-2) and inflammation related to cancer. Nutrition and Cancer, 70(3), 350-375. https://doi.org/10.1080/01635581.2018.1446091
Galati, R. (2012). The role of cyclooxygenase-2, epidermal growth factor receptor and aromatase in malignant mesothelioma. In Malignant mesothelioma. IntechOpen. https://doi.org/10.5772/50674
Hanahan, D., and Weinberg, R. A. (2011) Hallmarks of cancer: the next generation, Cell, 144, 646-674.
Dmitrieva OS, Shilovskiy IP, Khaitov MR, et at al. Interleukins 1 and 6 as Main Mediators of Inflammation and Cancer. Biochemistry (Mosc). 2016 Feb; 81(2): 80-90. doi: 10.1134/S0006297916020024. PMID: 27260388.
Oshima, H., Matsunaga, A., Fujimura, T., Tsukamoto, T., Taketo, M. M., & Oshima, M. (2006). Carcinogenesis in mouse stomach by simultaneous activation of the wnt signaling and prostaglandin E2 pathway. Gastroenterology, 131 (4), 1086 Gastroenterology, 131(4), 1086-1095.
Dai M, Hu S, Liu CF, Jiang L, Yu W, Li ZL, Guo W, Tang R, Dong CY, Wu TH, Deng WG. BPTF cooperates with p50 NF-κB to promote COX-2 expression and tumour cell growth in lung cancer. Am J Transl Res. 2019;11:7398-7409. [PMC free article] [PubMed] [Google Scholar] [Ref list] Clemente SM, Martínez-Costa OH, Monsalve M, Samhan-Arias AK. Targeting Lipid Peroxidation for Cancer Treatment. Molecules. 2020;25 [Google Scholar] [Ref list]
Juttner, S., Cramer, T., Wessler, S., Walduck, A., Gao, F., Schmitz, F., et al. (2003). Helicobacter pylori stimulates host cyclooxygenase-2 gene transcription: critical importance of MEK/ERK-dependent activation of USF1/-2 and CREB transcription factors. Cellular Microbiology, 5(11), 821-834
Shao Y, Sun K, Xu W, Li XL, Shen H, Sun WH. Helicobacter pylori infection, gastrin and cyclooxygenase-2 in gastric carcinogenesis. world J Gastroenterol. 2014; 20:12860-12873. [PMC free article] [PubMed PubMed] [Google Scholar] [Ref list]
Nardone G, Rocco A, Vaira D, Staibano S, Budillon A, Tatangelo F, Sciulli MG, Perna F, Salvatore G, Di Benedetto M, De Rosa G, Patrignani P. Expression of COX -2, mPGE-synthase1, MDR-1 (P-gp), and Bcl-xL: a molecular pathway of H pylori-related gastric carcinogenesis. J Pathol. 2004;202:305- 312. [PubMed PubMed] [Google Scholar Google Scholar] [Ref list]
Oshima H, Oshima M. The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models. J Gastroenterol. 2012;47:97 -106. [PubMed PubMed] [Google Scholar Google Scholar] [Ref list]
Thiel A, Narko K, Heinonen M, Hemmes A, Tomasetto C, Rio MC, Haglund C, Mäkelä TP, Ristimäki A. Inhibition of cyclooxygenase-2 causes regression of gastric adenomas in trefoil factor 1 deficient mice. Int J Cancer. 2012;131:1032-1041. [PubMed] [Google Scholar Google Scholar] [Ref list]
Turini ME, DuBois RN. Cyclooxygenase-2: a therapeutic target. Annu Rev Med. 2002;53:35-57. doi: 10.1146/annurev.med.53.082901.103952. PMID. 11818462.
Ding, Y. B., Shi, R. H., Tong, J. D., et al. (2005). PGE2 up-regulates vascular endothelial growth factor expression in MKN28 gastric cancer cells via epidermal growth factor receptor signalling system. Experimental Oncology, 27(2), 108-113.
Yao, L., Liu, F., Hong, L., et al. (2011). The function and mechanism of COX-2 in angiogenesis of gastric cancer cells. Journal of Experimental & Clinical Cancer Research, 30, 13.
Mrena, J., Wiksten, J. P., Kokkola, A.,et at al. (2010). COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer. Tumour Biology, 31(1), 1 Tumour Biology, 31(1), 1-7.
Yuan, X. L., Chen, L., Li, M. X., et al. (2010). Elevated expression of Foxp3 in tumour-infiltrating treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX- 2-dependent manner. Clinical Immunology, 134(3), 277-288.
Oshima, H., Oshima, M., Inaba, K., & Taketo, M. M. (2004). Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice. The EMBO Journal, 23(7), 1669-1678.
Oshima, H., Matsunaga, A., Fujimura, T., et at al. (2006). Carcinogenesis in mouse stomach by simultaneous activation of the wnt signaling and prostaglandin E2 pathway. Gastroenterology, 131(4), 1086 Gastroenterology, 131(4), 1086-1095.
Oshima, H., Itadani, H., Kotani, H., et at al. (2009). Induction of prostaglandin E2 pathway promotes gastric hamartoma development with suppression of bone morphogenetic protein signalling. Cancer Research, 69(7), 2729-2733.
Oshima, H., Oguma, K., Du, Y. C., & Oshima, M. (2009). Prostaglandin E2, wnt, and BMP in gastric tumor mouse models. Cancer Science, 100(10), 1779-1785.
Nam, K. T., Hahm, K. B., Oh, S. Y., Yeo, M., Han, S. U., Ahn, B., et al. (2004). The selective cyclooxygenase-2 inhibitor nimesulide prevents helicobacter pylori-associated gastric cancer develop- ment in a mouse model. Clinical Cancer Research, 10(23), 8105- 8113.
JIANG Ning, HUANG Xuan, FAN Yihong et al. Systematic evaluation of the efficacy of combined Chinese and Western medicine in the treatment of gastric precancerous lesions[J]. Chinese Journal of Traditional Chinese Medicine, 2015, 33(01):149-154. DOI:10.13193/j.issn.1673-7717.2015.01.046.
Dai Minglong, Zhang Shoshan. Study on the efficacy of Resolving Blood Stasis, Detoxicating and Tongluo Formula in treating gastric precancerous lesions with gastric blood stasis and its effect on the expression of inflammatory factors, COX-2, PG I and G-17 in patients[J]. Sichuan Traditional Chinese Medicine, 2023, 41(01):118-122.
Gao Dong, Li Yi. Study on the effect of Fuxian anti-iso soup on the protein expression of P16, bcl-2, cox-2 and survivin in gastric mucosa of patients with gastric precancerous lesions[J]. Inner Mongolia Traditional Chinese Medicine, 2022, 41(11):37-39. DOI:10.16040/j. cnki.cn15-1101.2022.11.083.
LIU Jindi, LIU Yangyang, GU Qinghua et al. Effects of Xin Gastric Granules on the expression of key factors NF-κB and COX-2 in gastric mucosa of rats with gastric precancerous lesions[J]. Journal of Chinese Traditional Medicine,2019,37(10):2354-2357+2569.DOI:10.13193/j.issn.1673-7717.2019.10.011.
Yin Jing. Exploring the mechanism of action of Gastric Ki Drink in the treatment of chronic atrophic gastritis based on COX-2/HIF-1α/VEGF pathway[D]. Shanghai University of Traditional Chinese Medicine, 2019. DOI:10.27320/d.cnki.gszyu.2019.000319.
ZHENG Huanfen, KANG Jianyuan, LI Jian et al. Efficacy of atrophic stomach granules in treating chronic atrophic gastritis and its effect on COX-2[J]. Shandong Journal of Traditional Chinese Medicine, 2019, 38(04): 335-338.DOI:10.16295/j.cnki.0257-358x.2019.04.009.
Tian F. Effect of compound formula chemotaxis and detoxification soup combined with DCF chemotherapy regimen on serum VEGF and COX-2 levels in patients with middle and advanced gastric cancer[J]. Journal of Modern Combination of Chinese and Western Medicine, 2017,26(24):2698-2700.
BAI Yuning, ZHANG Ping, LI Li et al. Effect of Strengthening the Spleen and Tongluo Detoxification Formula on the expression of COX-2, NF-κBp65 and Bcl-2 in gastric mucosa of patients with gastric precancerous lesions[J]. Chinese Journal of Integrative Medicine and Western Medicine,2015,35(02):167-173.
LIU Qiquan, LI Bolin, WANG Zhikun et al. Clinical study on the treatment of gastric precancerous lesions by Xiao Gui Shao, a formula for resolving turbidity and detoxifying toxins[J]. Sichuan Traditional Chinese Medicine,2014,32(06):90-92.
BAI Haiyan, LIU Qiquan, WANG Wei et al. Clinical study on the treatment of patients with chronic atrophic gastritis with precancerous lesions by Guilian Gastric Kang Fang[J]. Chinese patent medicine, 2012, 34(06): 991-994.
ZHAO Weihan, LI Junxiang, LI Junqing et al. Study on the regulatory effect of ginseng qi plankton-eliminating granules on COX-2 and Bcl-2 in rats with chronic atrophic gastritis[J]. Chinese Journal of Integrative Medicine and Digestion,2016,24(06):433-437.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Chunhua Xi, Ruotong Cao, Jialin Shen, Weihan Zhao
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
